PT  - JOURNAL ARTICLE
AU  - STEFANOS BONOVAS
AU  - ARGIRIOS TSANTES
AU  - THEOFANIS DROSOS
AU  - NIKOLAOS M. SITARAS
TI  - Cancer Chemoprevention: A Summary of the Current Evidence
DP  - 2008 May 01
TA  - Anticancer Research
PG  - 1857--1866
VI  - 28
IP  - 3B
4099  - http://ar.iiarjournals.org/content/28/3B/1857.short
4100  - http://ar.iiarjournals.org/content/28/3B/1857.full
SO  - Anticancer Res2008 May 01; 28
AB  - Cancer chemoprevention is defined as the use of natural, synthetic, or biological chemical agents to reverse, suppress, or prevent either the initial phase of carcinogenesis or the progression of neoplastic cells to cancer. At present, the circle of agents with an established chemopreventive effect is restricted to tamoxifen and raloxifene in breast cancer, finasteride in prostate cancer, and celecoxib in colon polyp prevention. However, in recent years, there has been an exponential increase in the study of agents that have a chemopreventive potential against cancer. In this review, the current evidence regarding cancer chemoprevention in major target organs is summarised, discussing the epidemiological as well as the experimental data. Copyright© 2008 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved